Exhaled nitric oxide levels in exacerbations of asthma, chronic obstructive pulmonary disease and pneumonia

Citation
Mk. Al-ali et Ph. Howarth, Exhaled nitric oxide levels in exacerbations of asthma, chronic obstructive pulmonary disease and pneumonia, SAUDI MED J, 22(3), 2001, pp. 249-253
Citations number
25
Categorie Soggetti
General & Internal Medicine
Journal title
SAUDI MEDICAL JOURNAL
ISSN journal
03795284 → ACNP
Volume
22
Issue
3
Year of publication
2001
Pages
249 - 253
Database
ISI
SICI code
0379-5284(200103)22:3<249:ENOLIE>2.0.ZU;2-W
Abstract
Objective: Nitric oxide is known to be present in the exhaled air of normal subjects and at higher concentrations in asthmatics. The aim of this study was to measure exhaled nitric oxide levels in patients admitted to hospita l with acute exacerbations of asthma, or chronic obstructive pulmonary dise ase. or with pneumonia. Methods: Within 24 hours of admission exhaled nitric oxide levels were meas ured by a chemiluminescent analyzer in 11 patients with acute sever asthma, 19 patients with acute exacerbation of chronic obstructive pulmonary disea se, and in 12 patients with pneumonia, In asthmatics measurements were made on 3 occasions. at day 1, 4, and 28 and were related to changes in peak ex piratory flow rate. Results: On admission median exhaled nitric oxide levels (range) were signi ficantly higher in asthmatics 22 (9.3-74) parts per billion in comparison t o patients with chronic obstructive pulmonary disease 10.3 (2.7-34) parts p er billion; p <0.01, pneumonia 7 (4-17) parts per billion, p <0.001, and no rmal subjects: 8.7 (5-13.3) parts per billion; p<0.001. Following treatment the asthmatics had significant reduction in their exhaled nitric oxide lev els from 22 (9.3-74) parts per billion on day 1 to 9.7 (5.7-18.3) parts per billion on day 28; p=0.005. Peak expiratory flow rate measurements increas ed from 200 (120-280) l/min on day 1 to 280 (150-475) l/min on day 4; p<les s than>0.05 and to 390 (150-530) l/min on day 28: p<0.01. A strong negative correlation existed between peak expiratory flow rare measurements and exh aled nitric oxide levels in asthmatics on day 28 (r=-0.70; p=0.017). Conclusion: Acute exacerbations of asthma are associated with increased lev els of exhaled nitric oxide in contrast to exacerbations of chronic obstruc tive pulmonary disease and acute pneumonia. Exhaled nitric oxide may be a u seful indirect marker of asthmatic airway inflammation. The differing time course of response of nitric oxide to peak flow measures suggests that thes e two measures are reflecting differing airway events.